StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) shareholders

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)

Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
53M of 51M shares
Institutional holders
252
53 new, 22 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 19 sales
Net sold $5.06M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.7,837,48415.40%13G (passive) amendmentSep 30, 2026
Wellington Management Group LLP
Joint filing with Wellington Group Holdings LLP (8.00%), Wellington Investment Advisors Holdings LLP (8.00%) and 1 more
3,969,2698.00%13G (passive)Jun 30, 2025
Vanguard Portfolio Management3,676,3037.22%13G (passive) amendmentSep 30, 2026
Wellington Investment Advisors Holdings LLP
Joint filing with Wellington Management Group LLP (6.80%), Wellington Group Holdings LLP (6.80%) and 1 more
3,382,5556.80%13G (passive) amendmentMar 31, 2026
Hood River Capital Management LLC3,096,6116.23%13G (passive) amendmentDec 31, 2025
AllianceBernstein L.P.2,768,3655.50%13G (passive) amendmentJun 30, 2026
Vanguard Capital Management2,532,9655.08%13G (passive)Mar 31, 2026
Macquarie Management Holdings Inc
Joint filing with Macquarie Group Limited (5.06%), Macquarie Investment Management Business Trust (5.06%)
2,503,2055.06%13G (passive)Jun 30, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ATRCValueChange% of portfolio
BlackRock, Inc.4,474,5488.80%$125.20M+431,8670.00%
Wellington Management Group Llp3,495,6036.87%$97.81M+113,0480.02%
Vanguard Portfolio Management LLC3,127,1956.15%$87.50M+424,5630.00%
Hood River Capital Management LLC2,905,2995.71%$81.29M−212,2460.59%
Alliancebernstein L.P.2,768,3655.44%$78.98M−490,5070.03%
Vanguard Capital Management LLC2,190,4134.31%$61.29M+34,6490.00%
Nomura Asset Management International Inc.1,734,2793.41%$48.53M−70,6480.07%
Goldman Sachs Group Inc1,597,9883.14%$44.71M−69,1780.00%
State Street Corp1,389,9892.73%$38.94M+87,8270.00%
Marshall Wace, Llp1,333,9042.62%$37.32M−133,6200.03%
Geode Capital Management, LLC1,319,6872.59%$36.93M+93,5710.00%
Arrowstreet Capital, Limited Partnership1,296,2092.55%$36.27M+1,018,5270.02%
Dimensional Fund Advisors LP1,044,0342.05%$29.22M+46,2750.01%
GW&K Investment Management, LLC949,5161.87%$26.57M−13,8990.21%
Neuberger Berman Group LLC947,9821.86%$26.58M−102,3000.02%
Champlain Investment Partners, LLC938,5671.85%$26.26M−32,5440.67%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.897,4191.76%$25.11M−163,3870.03%
Bank Of America Corp /De/874,3701.72%$24.46M+105,8090.00%
Kennedy Capital Management LLC857,7871.69%$24.00M+23,6320.42%
Divisadero Street Capital Management, LP800,9311.57%$22.41M−359,0240.51%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202625253M100.0%53 / 10261 / 227M5M
Q1 202622450M98.3%35 / 8366 / 4111M5M
Q4 202523449M95.9%36 / 9174 / 216M6M
Q3 202522348M95.1%34 / 7082 / 113M4M
Q2 202520149M96.3%17 / 7872 / 356M7M
Q1 202522150M99.1%38 / 7764 / 288M3M
Q4 202421347M91.5%39 / 6973 / 233M6M
Q3 202420250M97.6%40 / 5879 / 3410M6M
Q2 202419851M100.0%26 / 10252 / 519M9M
Q1 202422452M100.0%33 / 8481 / 4010M6M
Q4 202323348M94.4%40 / 10270 / 336M3M
Q3 202323045M89.2%29 / 9379 / 203M3M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

248 funds held ATRC in Q2 2026, 37% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ATRCValue% of fundAs of
Hood River Small-Cap Growth Fund1,527,0733.00%$42.73M0.64%Jun 30, 2026
Vanguard Total Stock Market Index Fund1,519,3122.99%$42.51M0.00%Jun 30, 2026
iShares Russell 2000 ETF1,296,7452.55%$36.28M0.04%Jun 30, 2026
Nomura Small Cap Core Fund1,219,5262.40%$33.74M0.61%May 29, 2026
Vanguard Small-Cap Index Fund1,102,1132.17%$30.84M0.02%Jun 30, 2026
Ab Discovery Growth Fund, Inc.737,6241.45%$20.64M0.71%Jun 30, 2026
Vanguard Small-Cap Growth Index Fund632,8511.24%$17.71M0.04%Jun 30, 2026
Vanguard Extended Market Index Fund580,4891.14%$16.24M0.02%Jun 30, 2026
Fidelity Small Cap Index Fund545,3921.07%$20.59M0.06%Jul 31, 2026
Fidelity Enhanced Small Cap Core ETF461,3900.91%$12.91M0.22%Jun 30, 2026
iShares Russell 2000 Growth ETF460,8710.91%$12.90M0.08%Jun 30, 2026
Champlain Small Company Fund383,0000.75%$10.72M1.29%Jun 30, 2026
Osterweis Opportunity Fund353,9850.70%$9.90M2.59%Jun 30, 2026
MFS New Discovery Fund341,8660.67%$9.46M0.44%May 31, 2026
EQ/AB Small Cap Growth Portfolio305,3450.60%$8.54M0.38%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Michael H. CarrelPresident, CEO, & Director796,6941.57%Aug 3, 2026
Salvatore PriviteraChief Technical Officer134,3410.26%Nov 5, 2026
Karl S. DahlquistChief Legal Officer87,3190.17%Aug 26, 2026
Justin J. NozneskyChief Mktg & Strategy Officer100,2190.20%Jul 30, 2026
Vinayak DoraiswamyChief Scientific Officer86,5110.17%Jul 30, 2026
Douglas J. SeithChief Operating Officer229,8670.45%Jul 2, 2026
Angela L. WirickChief Financial Officer204,8930.40%Mar 3, 2026
Deborah Lee YountChief Human Resources Officer57,5390.11%Mar 4, 2025
B. Kristine JohnsonDirector53,5020.11%Nov 10, 2026
Regina E. GrovesDirector34,5460.07%Sep 14, 2026
Maggie YuenDirector14,0150.03%Aug 7, 2026
Karen PrangeDirector22,8090.04%Aug 7, 2026
Sven WehrweinDirector40,5180.08%Jul 30, 2026
Deborah H. TelmanDirector28,3280.06%May 20, 2026
Robert S. WhiteDirector128,3180.25%May 20, 2026
Shlomo NachmanDirector24,6550.05%May 20, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
B. Kristine Johnson
Director
Nov 6, 2026Sale−2,452$58.48$143.39K53,502
Salvatore Privitera
Chief Technical Officer
Nov 4, 2026Sale(10b5-1 plan)−8,404$65.00$546.26K134,341
Salvatore Privitera
Chief Technical Officer
Sep 23, 2026Sale(10b5-1 plan)−4,519$60.00$271.14K142,745
Regina E. Groves
Director
Sep 11, 2026Sale−5,313$54.22$288.07K34,546
Salvatore Privitera
Chief Technical Officer
Sep 8, 2026Sale(10b5-1 plan)−3,657$55.00$201.14K147,264
Salvatore Privitera
Chief Technical Officer
Sep 2, 2026Sale(10b5-1 plan)−7,763$52.50$407.56K150,921
Karl S. Dahlquist
Chief Legal Officer
Aug 24, 2026Sale−9,370$48.89$458.10K87,319
Maggie Yuen
Director
Aug 5, 2026Sale−3,500$38.42$134.47K14,015
Karen Prange
Director
Aug 5, 2026Sale−3,564$38.80$138.28K22,809
Michael H. Carrel
President, CEO, & Director
Jul 30, 2026Gift−700––778,434
Michael H. Carrel
President, CEO, & Director
Jul 30, 2026Gift−4,000––774,434
Justin J. Noznesky
Chief Mktg & Strategy Officer
Jul 29, 2026Sale−6,182$38.80$239.86K100,219
Vinayak Doraiswamy
Chief Scientific Officer
Jul 28, 2026Sale−6,000$38.88$233.28K86,511
Sven Wehrwein
Director
Jul 28, 2026Sale−25,000$37.84$946.00K40,518
Sven Wehrwein
Director
Jul 28, 2026Option exercise+25,000$19.95$498.75K65,518
Salvatore Privitera
Chief Technical Officer
Jun 30, 2026Award+636$23.78$15.12K158,684
Douglas J. Seith
Chief Operating Officer
Jun 30, 2026Award+527$23.78$12.53K229,867
Karl S. Dahlquist
Chief Legal Officer
Jun 30, 2026Award+636$23.78$15.12K96,689
Vinayak Doraiswamy
Chief Scientific Officer
Jun 30, 2026Award+636$23.78$15.12K92,511
Michael H. Carrel
President, CEO, & Director
Jun 30, 2026Award+636$23.78$15.12K779,134
Karen Prange
Director
May 20, 2026Sale−3,000$28.65$85.95K26,373
Deborah H. Telman
Director
May 18, 2026Award+6,144––28,328
Robert S. White
Director
May 18, 2026Award+6,144––128,318
Karen Prange
Director
May 18, 2026Award+6,144––29,373
Sven Wehrwein
Director
May 18, 2026Award+6,144––40,518
Regina E. Groves
Director
May 18, 2026Award+6,144––39,859
Maggie Yuen
Director
May 18, 2026Award+6,144––17,515
B. Kristine Johnson
Director
May 18, 2026Award+6,144––55,954
Shlomo Nachman
Director
May 18, 2026Award+6,144––24,655
Vinayak Doraiswamy
Chief Scientific Officer
May 15, 2026Sale−5,000$28.13$140.65K91,875
Vinayak Doraiswamy
Chief Scientific Officer
Mar 12, 2026Sale−5,000$29.83$149.15K96,875
Robert S. White
Director
Mar 10, 2026Option exercise+10,000$14.99$149.90K122,174
Michael H. Carrel
President, CEO, & Director
Mar 6, 2026Gift−1,000––778,498
Michael H. Carrel
President, CEO, & Director
Mar 6, 2026Gift−5,000––779,498
Justin J. Noznesky
Chief Mktg & Strategy Officer
Mar 1, 2026Tax withholding−15,586$31.26$487.22K106,401
Justin J. Noznesky
Chief Mktg & Strategy Officer
Mar 1, 2026Award+27,991––106,789
Justin J. Noznesky
Chief Mktg & Strategy Officer
Mar 1, 2026Award+15,198––121,987
Angela L. Wirick
Chief Financial Officer
Mar 1, 2026Tax withholding−22,965$31.26$717.89K204,893
Angela L. Wirick
Chief Financial Officer
Mar 1, 2026Award+23,101––227,858
Angela L. Wirick
Chief Financial Officer
Mar 1, 2026Award+39,987––204,757
Douglas J. Seith
Chief Operating Officer
Mar 1, 2026Tax withholding−22,948$31.26$717.35K229,340
Douglas J. Seith
Chief Operating Officer
Mar 1, 2026Award+42,386––226,756
Douglas J. Seith
Chief Operating Officer
Mar 1, 2026Award+25,532––252,288
Karl S. Dahlquist
Chief Legal Officer
Mar 1, 2026Award+27,991––96,542
Karl S. Dahlquist
Chief Legal Officer
Mar 1, 2026Tax withholding−15,687$31.26$490.38K96,053
Karl S. Dahlquist
Chief Legal Officer
Mar 1, 2026Award+15,198––111,740
Vinayak Doraiswamy
Chief Scientific Officer
Mar 1, 2026Tax withholding−15,585$31.26$487.19K101,875
Vinayak Doraiswamy
Chief Scientific Officer
Mar 1, 2026Award+15,198––117,460
Vinayak Doraiswamy
Chief Scientific Officer
Mar 1, 2026Award+30,390––102,262
Michael H. Carrel
President, CEO, & Director
Mar 1, 2026Tax withholding−72,777$31.26$2.28M784,498
Michael H. Carrel
President, CEO, & Director
Mar 1, 2026Award+101,280––857,275
Michael H. Carrel
President, CEO, & Director
Mar 1, 2026Award+68,618––755,995
Salvatore Privitera
Chief Technical Officer
Mar 1, 2026Award+30,390––155,977
Salvatore Privitera
Chief Technical Officer
Mar 1, 2026Award+15,198––171,175
Salvatore Privitera
Chief Technical Officer
Mar 1, 2026Tax withholding−13,127$31.26$410.35K158,048
Douglas J. Seith
Chief Operating Officer
Dec 31, 2025Award+257$27.37$7.03K184,370
Michael H. Carrel
President, CEO, & Director
Dec 10, 2025Gift−4,000––687,377
Justin J. Noznesky
Chief Mktg & Strategy Officer
Nov 26, 2025Sale−5,166$37.29$192.64K78,798
Sven Wehrwein
Director
Nov 25, 2025Sale−4,967$38.00$188.75K34,374
Sven Wehrwein
Director
Nov 25, 2025Option exercise+4,967$19.95$99.09K39,341

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
10.02%
5M shares short
Days to cover
7.6
At 1M shares a day
Change since last report
+0.1%
From 5M shares
Short volume, 20 days
60.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of AtriCure's stock actually held short. Settlement fails (shares not delivered on time) peaked at 63,982 shares on Sep 21, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
B Kristine Johnson Declaration Trust
Director
Nov 6, 20262,452$143.40KNov 6, 2026Restricted Stock Vesting Under a Registered Plan
Salvatore Privitera
Officer
Nov 4, 20268,404$546.26KNov 4, 2026Restricted Stock
Salvatore Privitera
Officer
Sep 23, 20264,519$271.14KSep 23, 2026Performance Shares
Regina E. Groves
Director
Sep 11, 20265,313$285.10KSep 10, 2026Stock Award
Salvatore Privitera
Officer
Sep 8, 20263,657$201.14KSep 8, 2026Performance Shares
Salvatore Privitera
Officer
Sep 2, 20267,763$407.56KSep 2, 2026Restricted Stock
Karl S. Dahlquist
Officer
Aug 24, 20269,370$458.09KAug 24, 2026Performance Shares
Maggie Yuen
Director
Aug 5, 20263,500$134.47KAug 5, 2026Restricted Stock
Karen Prange
Director
Aug 5, 20263,564$139.00KAug 5, 2026Stock Award
Justin J. Noznesky
Officer
Jul 29, 20266,182$239.88KJul 29, 2026STOCK GRANT
Sven Wehrwein
Director
Jul 28, 202625,000$964.44KJul 28, 2026Stock Option Exercise
Vinayak Doraiswamy
Officer
Jul 28, 20266,000$233.28KJul 28, 2026Performance Shares
Karen Prange
Director
May 20, 20263,000$86.40KMay 20, 2026Stock Award
Vinayak Doraiswamy
Officer
May 15, 20265,000$140.67KMay 15, 2026Performance Shares
Vinayak Doraiswamy
Officer
Mar 12, 20265,000$149.15KMar 12, 2026Performance Shares

Congress trades

13 trades in AtriCure reported by 2 members of the House

MemberTypeTradedAmountFiled
Gilbert Cisneros
CA31
Sold (part)Sep 29, 2026$1K–15KOct 12, 2026
Gilbert Cisneros
CA31
BoughtAug 20, 2026$1K–15KSep 10, 2026
Gilbert Cisneros
CA31
BoughtMar 3, 2026$1K–15KApr 7, 2026
Gilbert Cisneros
CA31
BoughtMay 6, 2025$1K–15KJun 6, 2025
Josh Gottheimer
NJ05 · joint account
BoughtJul 19, 2024$1K–15KAug 15, 2024
Josh Gottheimer
NJ05 · joint account
SoldJun 18, 2024$1K–15KJul 9, 2024
Josh Gottheimer
NJ05 · joint account
Sold (part)Jun 8, 2021$1K–15KJul 15, 2021
Gilbert Cisneros
CA31
Sold (part)Apr 30, 2020$1K–15KMay 13, 2020
Gilbert Cisneros
CA31
BoughtMar 31, 2020$1K–15KApr 16, 2020
Gilbert Cisneros
CA31
Sold (part)Feb 21, 2020$1K–15KMar 10, 2020
Gilbert Cisneros
CA31
BoughtNov 7, 2019$1K–15KDec 11, 2019
Gilbert Cisneros
CA31
BoughtJun 27, 2019$1K–15KJul 12, 2019
Gilbert Cisneros
CA31
BoughtMay 8, 2019$1K–15KJun 18, 2019

See a number that looks wrong?